ENHANCEMENT OF ANTI-TUMOR ACTIVITY OF ADRIAMYCIN BY TWEEN-80

[1] ADRIAMYCIN - TOXICITY DATA [J]. EXPERIENTIA, 1970, 26 (04): : 389 - &

[2] BONMASSAR E, 1969, Archivio Italiano di Patologia e Clinica dei Tumori, V12, P163

[3] Bossa R, 1973, G Ital Chemioter, V20, P55

[4] ADRIAMYCIN - REVIEW [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (06) : 1265 - 1274

[5] DIMARCO A, 1975, CANCER CHEMOTH REP 3, V6, P91

[6] DIMARCO A, 1976, IRCS MED SCI, V4, P452

[7] AFFINITY OF ADRIAMYCIN TO PHOSPHOLIPIDS A POSSIBLE EXPLANATION FOR CARDIAC MITOCHONDRIAL LESIONS [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1976, 71 (02) : 658 - 663

[8] GALL D, 1966, IMMUNOLOGY, V11, P369

[9] GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1

[10] GIULIANI F, 1974, BIOMED EXPRESS, V21, P435

[1] ADRIAMYCIN - TOXICITY DATA [J]. EXPERIENTIA, 1970, 26 (04): : 389 - &

[2] BONMASSAR E, 1969, Archivio Italiano di Patologia e Clinica dei Tumori, V12, P163

[3] Bossa R, 1973, G Ital Chemioter, V20, P55

[4] ADRIAMYCIN - REVIEW [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (06) : 1265 - 1274

[5] DIMARCO A, 1975, CANCER CHEMOTH REP 3, V6, P91

[6] DIMARCO A, 1976, IRCS MED SCI, V4, P452

[7] AFFINITY OF ADRIAMYCIN TO PHOSPHOLIPIDS A POSSIBLE EXPLANATION FOR CARDIAC MITOCHONDRIAL LESIONS [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1976, 71 (02) : 658 - 663

[8] GALL D, 1966, IMMUNOLOGY, V11, P369

[9] GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1

[10] GIULIANI F, 1974, BIOMED EXPRESS, V21, P435